Characterizing CFTR modulated sweat chloride response across the cf population: Initial results from the CHEC-SC study-Reference-Cited by-同舟云学术

Characterizing CFTR modulated sweat chloride response across the cf population: Initial results from the CHEC-SC study

Published:2023-01 Issue:1 Volume:22 Page:79-88
ISSN:1569-1993
Container-title:Journal of Cystic Fibrosis
language:en
Short-container-title:Journal of Cystic Fibrosis

Author:

Mayer-Hamblett N,Zemanick ET^ORCID,Odem-Davis K^ORCID,VanDevanter D^ORCID,Warden M^ORCID,Rowe SM^ORCID,Young J,Konstan MW^ORCID,for-the-CHEC-SC-Study-Group

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Pediatrics, Perinatology and Child Health

Reference34 articles.

1. Origins of cystic fibrosis lung disease;Stoltz;N Engl J Med,2015

2. Diagnosis of cystic fibrosis: consensus guidelines from the cystic fibrosis foundation;Farrell;J Pediatr,2017

3. Cystic fibrosis: emergence of highly effective targeted therapeutics and potential clinical implications;Mall;Am J Respir Crit Care Med,2020

4. A CFTR potentiator in patients with cystic fibrosis and the G551D mutation;Ramsey;N Engl J Med,2011

5. Elexacaftor-tezacaftor-ivacaftor for cystic fibrosis with a single phe508del allele;Middleton;N Engl J Med,2019

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real‐world data confirm elexacftor/tezacaftor/ivacaftor modulators halves sweat chloride concentration in eligible people with cystic fibrosis;APMIS;2024-08-02

2. Heterogeneity of CFTR modulator-induced sweat chloride concentrations in people with cystic fibrosis;Journal of Cystic Fibrosis;2024-07

3. Understanding and addressing the needs of people with cystic fibrosis in the era of CFTR modulator therapy;The Lancet Respiratory Medicine;2023-10

4. CFTR modulator therapy: transforming the landscape of clinical care in cystic fibrosis;The Lancet;2023-09

5. Sex differences in outcomes of people with cystic fibrosis treated with elexacaftor/tezacaftor/ivacaftor;Journal of Cystic Fibrosis;2023-05